Eledon Pharmaceuticals Has Priced Its Underwritten Offering Of 18.4M Shares At $3.65/Share And Pre-funded Warrants To Purchase Up To 4.9M Shares At $3.649/Pre-funded Warrant, With Gross Proceeds Of Approximately $85M
Author: Benzinga Newsdesk | October 29, 2024 07:59am